JS, L., Y, Z., S, S., L, X., HL, Z., JL, P., & Y, P. (2017). Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone. Dove Medical Press.
Style de citation Chicago (17e éd.)JS, Liu, Zeng Y, Shi S, Xu L, Zhang HL, Pathak JL, et Pan Y. Design of Polyaspartic Acid Peptide-poly (ethylene Glycol)-poly (ε-caprolactone) Nanoparticles as a Carrier of Hydrophobic Drugs Targeting Cancer Metastasized to Bone. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)JS, Liu, et al. Design of Polyaspartic Acid Peptide-poly (ethylene Glycol)-poly (ε-caprolactone) Nanoparticles as a Carrier of Hydrophobic Drugs Targeting Cancer Metastasized to Bone. Dove Medical Press, 2017.